| scholarly article | Q13442814 |
| P2093 | author name string | Markus Schirle | |
| Esther K Schmitt | |||
| David Estoppey | |||
| Dominic Hoepfner | |||
| Philipp Krastel | |||
| Ralph Riedl | |||
| Thomas Aust | |||
| Trixie Wagner | |||
| Xuewen Pan | |||
| Nathan T Ross | |||
| Jason Thomas | |||
| Howard Miller | |||
| Kathrin Buntin | |||
| Francesca Perruccio | |||
| Silvio Roggo | |||
| Eric Weber | |||
| Felipa Mapa | |||
| Xiaobing Xie | |||
| Klaus Memmert | |||
| Peter Aspesi | |||
| Brigitta Liechty | |||
| Christian Thibaut | |||
| P2860 | cites work | A new antibiotic kills pathogens without detectable resistance | Q24091299 |
| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity | Q29547693 | ||
| Discovery, Structure Elucidation, and Biological Characterization of Nannocystin A, a Macrocyclic Myxobacterial Metabolite with Potent Antiproliferative Properties | Q35648635 | ||
| P433 | issue | 35 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 10149-10154 | |
| P577 | publication date | 2015-07-15 | |
| P1433 | published in | Angewandte Chemie International Edition | Q62023953 |
| P1476 | title | Nannocystin A: an Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti-Cancer Properties | |
| P478 | volume | 54 |
| Q64099700 | ()-α-Boryl-crotylboron reagents -selective alkene isomerization and application to stereoselective syntheses of ()-δ-boryl--homoallylic alcohols |
| Q48223572 | Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights. |
| Q37430049 | Decoding Mammalian Ribosome-mRNA States by Translational GTPase Complexes |
| Q47215208 | Engineered polyketides: Synergy between protein and host level engineering. |
| Q58856786 | Hot off the press |
| Q90389268 | Kendomycin Cytotoxicity against Bacterial, Fungal, and Mammalian Cells Is Due to Cation Chelation |
| Q52863701 | Molecular and functional characterization of myxobacteria isolated from soil in India. |
| Q38599715 | Natural products as probes in pharmaceutical research |
| Q39025967 | Natural products from myxobacteria: novel metabolites and bioactivities. |
| Q33364593 | Solving the Puzzle of One-Carbon Loss in Ripostatin Biosynthesis |
| Q93389292 | Structural Basis of Polyketide Synthase O-Methylation |
| Q47813312 | Structural rationale for the cross-resistance of tumor cells bearing the A399V variant of elongation factor eEF1A1 to the structurally unrelated didemnin B, ternatin, nannocystin A and ansatrienin B. |
| Q30388201 | Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex. |
| Q39231472 | The Uncommon Enzymology of Cis-Acyltransferase Assembly Lines |
| Q50202571 | Total synthesis of nannocystin Ax. |
| Q41360384 | Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin. |
| Q37263956 | Treatment with didemnin B, an elongation factor 1A inhibitor, improves hepatic lipotoxicity in obese mice |
| Q36875123 | eEF1A1 binds and enriches protoporphyrin IX in cancer cells in 5-aminolevulinic acid based photodynamic therapy. |
Search more.